Related Experiment Video
Updated: May 24, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
A disintegrin and metalloenzyme (ADAM) 17 activation is regulated by α5β1 integrin in kidney mesangial cells
Pal Gooz1, Yujing Dang, Shigeki Higashiyama
1Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.
Background:
The disintegrin and metalloenzyme ADAM17 participates in numerous inflammatory and proliferative diseases, and its pathophysiological role was implicated in kidney fibrosis, polycystic kidney disease and other chronic kidney diseases. At present, we have little understanding how the enzyme activity is regulated. In this study we wanted to characterize the role of α5β1 integrin in ADAM17 activity regulation during G protein-coupled receptor (GPCR) stimulation.
Methodology/Principal Findings:
We showed previously that the profibrotic GPCR agonist serotonin (5-HT) induced kidney mesangial cell proliferation through ADAM17 activation and heparin-binding epidermal growth factor (HB-EGF) shedding. In the present studies we observed that in unstimulated mesangial cell lysates α5β1 integrin co-precipitated with ADAM17 and that 5-HT treatment of the cells induced dissociation of α5β1 integrin from ADAM17. Using fluorescence immunostaining and in situ proximity ligation assay, we identified the perinuclear region as the localization of the ADAM17/α5β1 integrin interaction. In cell-free assays, we showed that purified α5β1 integrin and β1 integrin dose-dependently bound to and inhibited activity of recombinant ADAM17. We provided evidence that the conformation of the integrin determines its ADAM17-binding ability. To study the effect of β1 integrin on ADAM17 sheddase activity, we employed alkaline phosphatase-tagged HB-EGF. Overexpression of β1 integrin lead to complete inhibition of 5-HT-induced HB-EGF shedding and silencing β1 integrin by siRNA significantly increased mesangial cells ADAM17 responsiveness to 5-HT.
Conclusions/Significance:
Our data show for the first time that β1 integrin has an important physiological role in ADAM17 activity regulation. We suggest that regulating α5β1 integrin binding to ADAM17 could be an attractive therapeutic target in chronic kidney diseases.
Insights
Beta-1 integrin regulates ADAM17 activity, impacting kidney disease progression. Targeting this interaction may offer new therapeutic strategies for chronic kidney diseases by controlling ADAM17 enzyme function.
Area of Science:
- Cell Biology
- Integrin Signaling
- Enzyme Regulation
Background:
- ADAM17 (a disintegrin and metalloenzyme) is implicated in inflammatory and proliferative kidney diseases.
- Understanding ADAM17 regulation is crucial for treating chronic kidney diseases like fibrosis and polycystic kidney disease.
- The role of α5β1 integrin in ADAM17 regulation during G protein-coupled receptor (GPCR) stimulation is largely unknown.
Purpose of the Study:
- To characterize the role of α5β1 integrin in regulating ADAM17 activity.
- To investigate the interaction between α5β1 integrin and ADAM17 during GPCR stimulation.
- To explore the therapeutic potential of targeting the α5β1 integrin-ADAM17 interaction in kidney diseases.
Main Methods:
- Co-immunoprecipitation to detect ADAM17/α5β1 integrin interaction in mesangial cell lysates.
- Fluorescence immunostaining and proximity ligation assays to determine interaction localization.
- Cell-free assays with purified proteins to assess binding and inhibition.
- Enzyme activity assays using HB-EGF shedding and β1 integrin modulation (overexpression/siRNA).
Main Results:
- α5β1 integrin co-precipitated with ADAM17 in unstimulated cells, dissociating upon 5-HT stimulation.
- ADAM17 and α5β1 integrin interaction occurs in the perinuclear region.
- Purified α5β1 integrin inhibited ADAM17 activity in a dose-dependent manner, influenced by integrin conformation.
- Overexpression of β1 integrin blocked 5-HT-induced HB-EGF shedding, while silencing β1 integrin enhanced ADAM17 activity.
Conclusions:
- β1 integrin plays a significant physiological role in regulating ADAM17 activity.
- The α5β1 integrin-ADAM17 interaction is a key regulatory mechanism.
- Targeting the binding between α5β1 integrin and ADAM17 presents a potential therapeutic strategy for chronic kidney diseases.
Related Concept Videos
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Intracellular Signaling Affects Focal Adhesions
Some...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin homology) domains...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Overview of Cell-Matrix Interactions
